Your browser doesn't support javascript.
loading
A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin®) in Healthy Chinese Males.
Wu, Jing; Wu, Guolan; Xie, Liangzhi; Lv, Duo; Xu, Chang; Zhou, Huili; Wu, Lihua; Zhang, Jingjing; Shentu, Jianzhong.
  • Wu J; Research Center of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wu G; Zhejiang University School of Medicine, Hangzhou, China.
  • Xie L; Research Center of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lv D; Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xu C; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Zhou H; Sinocelltech Ltd., No. 31 Kechuang 7th Street, BDA, Beijing, China.
  • Wu L; Research Center of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang J; Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shentu J; Research Center of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Drugs R D ; 23(2): 175-183, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37247166
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Bevacizumab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Bevacizumab Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article